Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

CASE: Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is reported the...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzaki, Toshiya, Iwasa, Takeshi, Kawakita, Takako, Yamamoto, Yuri, Abe, Akiko, Hayashi, Aki, Yano, Kiyohito, Nishimura, Masato, Kuwahara, Akira, Irahara, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046528/
https://www.ncbi.nlm.nih.gov/pubmed/30013435
http://dx.doi.org/10.1002/rmb2.12209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046528/
https://www.ncbi.nlm.nih.gov/pubmed/30013435
http://dx.doi.org/10.1002/rmb2.12209

Ejemplares similares